Why it was recalled
Superpotent Drug
Product description
DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0
Lot numbers, UPCs & expiration codes
Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022; R13637E, exp. date 06/2022
Where it was sold
Nationwide within the United States.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1504-2020
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- Jul 21, 2020
- FDA report date
- Aug 26, 2020
- Quantity
- 15,175 nasal sprays
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Ferring Pharmaceuticals Inc
Original FDA data
Every field from FDA enforcement report D-1504-2020, exactly as published.
Show all FDA fields
- City
- Parsippany
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 86066
- Address
- 100 Interpace Pkwy
- Code information
- Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022; R13637E, exp. date 06/2022
- Postal code
- 07054-1149
- Report date
- Aug 26, 2020
- Product type
- Drugs
- Recall number
- D-1504-2020
- Classification
- Class I
- Recalling firm
- Ferring Pharmaceuticals Inc
- Product quantity
- 15,175 nasal sprays
- Termination date
- Oct 13, 2023
- Reason for recall
- Superpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0
- Distribution pattern
- Nationwide within the United States.
- Recall initiation date
- Jul 21, 2020
- Initial firm notification
- Letter
- Center classification date
- Aug 17, 2020